Not a very impressive day, or week. Junius files S8 for to start selling shares. No significant news from ASCO. For those interested in ECYT, the stock is correcting from the recent 40% move up, $10 to $14.5 to $12. Hopefully, it's just a technical correction, I am starting to get interested at this price. ACAD and TSRX continue to work.